用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
Enzymotec Ltd.(14)
Board Of Regents, The University Of Texas System(12)
Doosan Corporation(11)
Bioghurt Biogarde Gmbh & Co. Kg(9)
FIDIA SPA(8)
Fidia, S.p.a.(6)
Biodelivery Sciences International, Inc.(5)
Kyungpook National University Industry-academic Cooperation Foundation(5)
Fidia S.p.a.(5)
NAGASE CHEMTEX CORP(5)
专利信息
Translation Company
查询条件
展开筛选条件
[药品] 包含 'Phosphatidylserine'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
3
4
5
6
下页
尾页
共
284
条记录, 当前第1/29页。
公开号
公开日
申请号
申请日
1.
CN103635181A
2014/3/12
专利标题
:The microencapsulation method of phosphatidylserine
专利权人
:
2.
US2014065148A1
2014/3/6
US201313936802
2013/7/8
专利标题
:TREATMENT METHODS USING ANTIBODIES TO AMINOPHOSPHOLIPIDS
专利权人
:
UNIV TEXAS [US]
;
Disclosed are the surprising discoveries that aminophospholipids, such as phosphatidylserine and phosphatidylethanolamine, are stable and specific markers accessible on the luminal surface of tumor blood vessels, and that the administration of an anti-aminophospholipid antibody alone is sufficient to induce thrombosis, tumor necrosis and tumor regression in vivo. This invention therefore provides anti-aminophospholipid antibody-based methods and compositions for use in the specific destruction o...
3.
US8658768B2
2014/2/25
专利标题
:Method for enhancing phagocytosis of phosphatidylserine-exposing cells
专利权人
:
Mosamedix B.v.
;
An Annexin A5 variant comprising one or more RGD (Arg-Gly-Asp) sequences is suitable for use in the treatment of a disease in mammals including humans wherein augmentation of phagocytosis is a desired effect of treatment. The Annexin A5 variant can e.g. be used in the treatment of chronic inflammatory diseases such as atherosclerotic plaque or in the treatment of COPD. At least one RGD sequence may substitute sequences of three amino acids within the range 1-19 or other regions of the amino acid...
4.
WO2014018535A1
2014/1/30
WO2013US51688
2013/7/23
专利标题
:REGULATING THE INTERACTION BETWEEN TAM LIGANDS AND LIPID MEMBRANES WITH EXPOSED PHOSPHATIDYLSERINE
专利权人
:
SALK INST FOR BIOLOGICAL STUDI [US]
;
XETRIOS THERAPEUTICS INC [US]
;
The present disclosure provides methods for modulating the interaction between a TAM ligand and a lipid membrane containing phosphatidyl serine (PtdSer). In one example, such methods use a TAM receptor agonist having a PtdSer -containing lipid bilayer membrane with Gas6 and/or Protein S bound to the membrane to activate signaling from one or more TAM receptors and treat an autoimmune disease. In another example, methods are provided for treating a subject with a pathological condition characteri...
5.
CN102716098B
2014/1/15
CN20121222235
2012/6/29
专利标题
:A kind of cefditoren pivoxil cephalosporins lipidosome solid preparation
专利权人
:
Hainan Meida Pharmaceutical Co., Ltd.
;
6.
CN103509047A
2014/1/15
专利标题
:The extraction process of phosphatidylcholine and the preparation method of phosphatidylserine in a kind of krill source
专利权人
:
7.
CN102716082B
2014/1/15
专利标题
:A kind of cefoxitin sodium lipidosome injection
专利权人
:
Hainan Lingkang Pharmaceutical Co., Ltd.
;
8.
US2013337088A1
2013/12/19
US201313970983
2013/8/20
专利标题
:METHODS FOR TREATING SCARS AND AGING SKIN
专利权人
:
WIDGEROW ALAN DAVID [US]
;
Beneficial topical compositions for treating scar or aging skin are provided. In one embodiment, the compositions include Bulbine frutescens, Centella asiatica and a phenol derived from olives, such as oleuropein. The composition may be used in the treatment of scars formed during surgery. The composition may also be used cosmeceutically in the treatment of aged skin, and may include phosphatidylserine, vitamins, and other beneficial anti-aging ingredients.
9.
KR20130137578A
2013/12/17
KR20130145867
2013/11/28
专利标题
:COMPOSITION FOR IMPROVEMENT OF SKIN WRINKLE CAUSED BY ULTRA VIOLET RADIATION COMPRISING PHOSPHATIDYLSERINE
专利权人
:
DOOSAN CORP [KR]
;
10.
WO2013184678A1
2013/12/12
WO2013US44108
2013/6/4
专利标题
:MOLECULAR PROBES FOR MULTIMODALITY IMAGING OF ANIONIC MEMBRANE SURFACES
专利权人
:
MOLECULAR TARGETING TECHNOLOGIES INC [US]
;
Embodiments provide dual modality probes for imaging phosphatidylserine (PS) exposure and other anionic membrane surfaces. In various embodiments, the probes were constructed by utilizing a) the high selectivity of synthetic zinc (II) dipicolylamine coordination complexes (Zn-DPA) for targeting externalized PS which over-expresses in apoptotic and necrotic cells, b) a near-infrared (NIR) dye for optical imaging, and c) a widely used clinically approved radionuclide for PET (or SPECT) imaging. A ...
首页
1
2
3
4
5
6
下页
尾页
共
284
条记录, 当前第1/29页。
当前查询条件: [药品] 包含 'Phosphatidylserine'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文